These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10875933)

  • 1. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells.
    Ratti S; Curnis F; Longhi R; Colombo B; Gasparri A; Magni F; Manera E; Metz-Boutigue MH; Corti A
    J Biol Chem; 2000 Sep; 275(38):29257-63. PubMed ID: 10875933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.
    Ferrero E; Scabini S; Magni E; Foglieni C; Belloni D; Colombo B; Curnis F; Villa A; Ferrero ME; Corti A
    FASEB J; 2004 Mar; 18(3):554-6. PubMed ID: 14734634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain.
    Gasparri A; Sidoli A; Sanchez LP; Longhi R; Siccardi AG; Marchisio PC; Corti A
    J Biol Chem; 1997 Aug; 272(33):20835-43. PubMed ID: 9252409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion.
    Colombo B; Longhi R; Marinzi C; Magni F; Cattaneo A; Yoo SH; Curnis F; Corti A
    J Biol Chem; 2002 Nov; 277(48):45911-9. PubMed ID: 12297497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
    Stridsberg M; Angeletti RH; Helle KB
    J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of residues in chromogranin A-(16-40) required for inhibition of parathyroid hormone secretion.
    Angeletti RH; Mints L; Aber C; Russell J
    Endocrinology; 1996 Jul; 137(7):2918-22. PubMed ID: 8770914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Ca(2+)-dependent calmodulin-binding region of chromogranin A.
    Yoo SH
    Biochemistry; 1992 Jul; 31(26):6134-40. PubMed ID: 1627556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
    Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
    Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
    Gill BM; Barbosa JA; Hogue-Angeletti R; Varki N; O'Connor DT
    Neuropeptides; 1992 Feb; 21(2):105-18. PubMed ID: 1372966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
    Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
    Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural vasostatin-containing peptides in rat heart.
    Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
    FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.
    Russell J; Gee P; Liu SM; Angeletti RH
    Endocrinology; 1994 Jul; 135(1):337-42. PubMed ID: 8013369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the secretory vesicle membrane binding region of chromogranin A.
    Kang YK; Yoo SH
    FEBS Lett; 1997 Mar; 404(1):87-90. PubMed ID: 9074643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.
    Tota B; Mazza R; Angelone T; Nullans G; Metz-Boutigue MH; Aunis D; Helle KB
    Regul Pept; 2003 Jul; 114(2-3):123-30. PubMed ID: 12832100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.
    Deftos LJ
    Endocr Rev; 1991 May; 12(2):181-7. PubMed ID: 2070778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A(344-364)): identification of amino acid residues crucial for activity.
    Mahata SK; Mahata M; Wakade AR; O'Connor DT
    Mol Endocrinol; 2000 Oct; 14(10):1525-35. PubMed ID: 11043569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
    Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
    Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
    Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
    Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon.
    Amato A; Corti A; Serio R; Mulè F
    Regul Pept; 2005 Aug; 130(1-2):42-7. PubMed ID: 15869818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.